glp 1 and immune system Frontiers Relevance of Glucagon-Like Peptide 1

Further, improved government initiatives and rising demand for new compounds are contributing toward strengthening the lead

These results established the potential of this new hormone as a therapy for diabetes, but a key problem persisted

View image online ( Older woman with obesity and glasses Evidence is mounting that glucagon-like peptide-1 (GLP-1) receptor agonist drugs used to treat diabetes and obesity have protective effects across numerous organ systems

However, both medications independently affect the gastrointestinal system, which requires careful consideration when used together

The phentermine prescribing information specifically warns against combining it with other weight loss medications